Monday, April 25, 2016 3:39:37 PM
SEC filings: http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Press Releases: http://cellceutix.com/category/press-release/
Recent News: http://finance.yahoo.com/q/h?s=CTIX+Headlines
Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
Clinical trials: https://clinicaltrials.gov/ct2/results/displayOpt?flds=a&flds=b&flds=f&flds=c&flds=p&submit_fld_opt=on&=Update+Display&term=cellceutix&show_flds=Y
Management: http://cellceutix.com/team/
Product Pipeline: http://cellceutix.com/pipeline
When reading the iHub board posts:
B = Brilacidin, new class of antibiotic called defensin-mimetic
http://cellceutix.com/brilacidin/#sthash.YILNlO7Z.dpbs
K = Kevetrin, the oncology drug
http://cellceutix.com/kevetrin/#sthash.wHW2BJAD.dpbs
P = Prurisol, the psoriasis drug
http://cellceutix.com/prurisol/#sthash.GP0Dc7Qd.dpbs
FDA designations: 3 Orphans, 1 QIDP, 1 Fast-track and 1 Rare-Pediatric for CTIX
Orphan: Pancreatic, Ovarian, Retinoblastoma
QIDP: Brilacidin
Fast-track: Oral Mucositis (OM)
Rare-Pediatric: Retinoblastoma
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
978.236.8717 Phone
978.921.6564 Fax
E-mail: info@cellceutix.com
CIK: 0001355250
All of above compiled by KarinCA
Three month Daily Chart:
Three year Weekly Chart:
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM